Fig. 3: Outcome after MAC vs RIC in MDS/sAM at landmark 12 months.

Overall survival (a), relapse-free survival (b), relapse incidence (c), non-relapse mortality (d), and chronic GVHD Incidence (e) according to treatment arm [myeloalative (MAC) versus reduced intensity conditioning (RIC)] as Landmark Analysis at 12 months.